Delivery Order SPE2DB20D1100-SPE2DB25FE3X7
Award Date 9/2/25
Potential Completion Date 9/23/25
Potential Value $50K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,374.96 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization protection against measles, mumps, rubella, and varicella, commonly used within military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $24,814.95 to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine indicated for prevention of measles, mumps, rubella, and varicella, representing a critical pharmaceutical supply for...
- The Defense Logistics Agency awarded a $49,629.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a competitively awarded, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity for military and...
- The Defense Logistics Agency awarded a delivery order valued at $8,354.50 to AmerisourceBergen Drug Corp for ProQuad vials on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price contract, which is not set-aside, is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and varicella, representing a critical pharmaceutical supply for military healthcare...
- The Defense Logistics Agency (DLA) awarded a $1,687.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 14, 2025, with a completion date of September 5, 2025. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella. This non-set-aside award was competitively procured and reflects AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to federal medical systems, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,740.40 to AmerisourceBergen Drug Corp for ProQuad vials on August 18, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to prevent measles, mumps, rubella, and varicella, making this procurement critical for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,168.24 to AmerisourceBergen Drug Corp for ProQuad vials. This is a firm fixed-price, non-set-aside contract with a completion deadline of August 19, 2025, issued on July 29, 2025. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, essential for military medical readiness and troop health maintenance. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $17,711.36 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity within the federal medical supply chain. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.33 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, making this...